Pfizer Inc.

Oxford AstraZeneca Covid vaccine approved by UK regulator

The momentum of the Brexit trade deal is fading

Sinopharm says Shot is 79% effective; Looking for public use in China

Sinopharm says Shot is 79% effective; Looking for public use in China

Update on Covid vaccine: US will fall short of target of 20 million doses by year end

Myovant share rises 27% on news of Pfizer partnership with prostate cancer drugs worth up to $ 4.2 billion

Stock futures flat as Wall Street was due to go into effect last week of 2020

EU starts vaccination campaign Covid-19

UK Lockdowns could ease in weeks with AstraZeneca Vaccine

China’s vaccines are poised to fill the gap, but are facing trust issues